Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Bariatric surgery980 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A48153 | 21168706 | Transplant Proc | The multicenter Belgian survey on liver transplantation for hepatocellular failure after bariatric surgery. | 2010 | Details |
| A48322 | 16617233 | Am J Med Sci | The effect of obesity surgery on obesity comorbidity. | 2006 | Details |
| A48396 | 12568185 | Obes Surg | Liver damage in obese patients. | 2002 | Details |
| A48541 | 34403079 | Obes Surg | Combined Nissen Fundoplication and Single Anastomosis Sleeve Ileal Bypass (N-SASI) as a Practical Modality of Bariatric Surgery (Video Report). | 2021 | Details |
| A48704 | 31089967 | Obes Surg | Quantification of Liver, Subcutaneous, and Visceral Adipose Tissues by MRI Before and After Bariatric Surgery. | 2019 | Details |
| A48722 | 30691442 | BMC Pediatr | Bariatric surgery in adolescents: a prospective randomized controlled trial comparing laparoscopic gastric banding to combined lifestyle interventions in adolescents with severe obesity (BASIC trial). | 2019 | Details |
| A48758 | 29519261 | Ned Tijdschr Geneeskd | [EndoBarrier as a treatment for obesity and diabetes]. | 2018 | Details |
| A48800 | 28281236 | Obes Surg | Simultaneous Liver Transplantation and Sleeve Gastrectomy: Prohibitive Combination or a Necessity? | 2017 | Details |
| A48899 | 25230385 | Rozhl Chir | Bariatric metabolic surgery. | 2014 | Details |
| A49039 | 20458850 | Acta Gastroenterol Belg | Rapidly evolving liver decompensation with some remarkable features 14 years after biliopancreatic derivation: a case report and literature review. | 2010 | Details |
| A49058 | 19785490 | Rev Esp Enferm Dig | Will non-invasive testing replace liver biopsy in the diagnosis and follow-up of non-alcoholic steatohepatitis (NASH)? | 2009 | Details |
| A49167 | 15649101 | Treat Endocrinol | Surgical management of obesity: a review of the evidence relating to the health benefits and risks. | 2005 | Details |
| A49183 | 15115430 | Med J Aust | 10: Management of obesity. | 2004 | Details |
| A49196 | 12940291 | Obes Surg | Hepatic steatosis in patients undergoing bariatric surgery and its relationship to body mass index and co-morbidities. | 2003 | Details |
| A49215 | 35820779 | Gut | Accurate liquid biopsy for the diagnosis of non-alcoholic steatohepatitis and liver fibrosis. | 2022 | Details |
| A49279 | 35803320 | Metabolism | Recent guidelines for non-alcoholic fatty liver disease (NAFLD): Are they already outdated and in need of supplementation? | 2022 | Details |
| A49283 | 35800999 | Ann Surg Treat Res | Short-term outcome of bariatric surgery on nonalcoholic fatty liver disease: a Korean perspective. | 2022 | Details |
| A49292 | 35797133 | JCI Insight | Altered branched-chain α-keto acid metabolism is a feature of NAFLD in individuals with severe obesity. | 2022 | Details |
| A49306 | 35792995 | Obes Surg | NASH Presence is Associated with a Lower Weight Loss One and 2 Years After Bariatric Surgery in Women with Severe Obesity. | 2022 | Details |
| A49320 | 35789605 | Dis Markers | Identification of Key Biomarkers and Immune Infiltration in Liver Tissue after Bariatric Surgery. | 2022 | Details |
| A49336 | 35784568 | Front Endocrinol (Lausanne) | Multi-Faceted Influence of Obesity on Type 1 Diabetes in Children - From Disease Pathogenesis to Complications. | 2022 | Details |
| A49340 | 35783879 | Cureus | Nonalcoholic Fatty Liver Disease: An Emerging Modern-Day Risk Factor for Cardiovascular Disease. | 2022 | Details |
| A49407 | 35760372 | Diabetes Metab | Prevalence and predictors of non-alcoholic steatohepatitis in subjects with morbid obesity and with or without type 2 diabetes. | 2022 | Details |
| A49508 | 35731891 | Sci Transl Med | Molecular signatures of long-term hepatocellular carcinoma risk in nonalcoholic fatty liver disease. | 2022 | Details |
| A49559 | 35713877 | Diabetes | Hyperinsulinemia is Highly Associated with Markers of Hepatocytic Senescence in Two Independent Cohorts. | 2022 | Details |
| A49560 | 35713854 | Obes Surg | Endoscopic Bariatric Treatment with Duodenal-Jejunal Bypass Liner Improves Non-invasive Markers of Non-alcoholic Steatohepatitis. | 2022 | Details |
| A49594 | 35697996 | Obes Surg | The Benefit of Bariatric Surgery on Histological Features of Metabolic Associated Fatty Liver Disease Assessed Through Noninvasive Methods. | 2022 | Details |
| A49687 | 35670949 | Obes Surg | Serum Ferritin and NAFLD in Patients Undergoing Bariatric Surgery. | 2022 | Details |
| A49693 | 35668285 | Hepatol Int | Chronic intermittent hypoxia contributes to non-alcoholic steatohepatitis progression in patients with obesity. | 2022 | Details |
| A49744 | 35651885 | Metabol Open | Effect of 8 Weeks milk thistle powder (silymarin extract) supplementation on fatty liver disease in patients candidates for bariatric surgery. | 2022 | Details |
| A49811 | 35629944 | Metabolites | Mendelian Randomization Analysis Identifies Blood Tyrosine Levels as a Biomarker of Non-Alcoholic Fatty Liver Disease. | 2022 | Details |
| A49865 | 35614896 | Visc Med | Diagnostic and Therapy of Nonalcoholic Fatty Liver Disease: A Narrative Review. | 2021 | Details |
| A49868 | 35614135 | Nat Commun | Influence of NAFLD and bariatric surgery on hepatic and adipose tissue mitochondrial biogenesis and respiration. | 2022 | Details |
| A49937 | 35588737 | Horm Metab Res | Insulin-Like Growth Factor-I Might be a Predictor for Severe Non-Alcoholic Fatty Liver Disease in Morbidly Obese Patients. | 2022 | Details |
| A49988 | 35569886 | Endocr Pract | American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings: Co-Sponsored by the American Association for the Study of Liver Diseases (AASLD). | 2022 | Details |
| A50014 | 35563425 | Int J Mol Sci | Plasma Aldo-Keto Reductase Family 1 Member B10 as a Biomarker Performs Well in the Diagnosis of Nonalcoholic Steatohepatitis and Fibrosis. | 2022 | Details |
| A50055 | 35543890 | Obes Surg | Roux-en-Y Gastric Bypass as a Treatment for Hepatic Iron Overload: An Exploratory Study. | 2022 | Details |
| A50166 | 35494531 | Diabetes Metab Syndr Obes | Current Perspectives on Nonalcoholic Fatty Liver Disease in Women with Polycystic Ovary Syndrome. | 2022 | Details |
| A50240 | 35461781 | Surg Obes Relat Dis | Outcomes of bariatric surgery in patients with obesity and compensated liver cirrhosis. | 2022 | Details |
| A50248 | 35457142 | Int J Mol Sci | Role of Branched-Chain Amino Acid Metabolism in Type 2 Diabetes, Obesity, Cardiovascular Disease and Non-Alcoholic Fatty Liver Disease. | 2022 | Details |
| A50293 | 35442320 | Arq Gastroenterol | SHOULD ROUTINE LIVER BIOPSY BE CONSIDERED IN BARIATRIC SURGICAL PRACTICE? AN ANALYSIS OF THE LIMITATIONS OF NON-INVASIVE NAFLD MARKERS. | 2022 | Details |
| A50357 | 35419698 | Obes Surg | Reversal of NAFLD After VSG Is Independent of Weight-Loss but RYGB Offers More Efficacy When Maintained on a High-Fat Diet. | 2022 | Details |
| A50390 | 35407364 | J Clin Med | Improvement of Type 2 Diabetes Mellitus and Attenuation of NAFLD Are Associated with the Success of Obesity Therapy. | 2022 | Details |
| A50427 | 35396116 | Endocrinol Diabetes Nutr (Engl Ed) | Prevalence and predictors of non-alcoholic steatohepatitis in patients with morbid obesity. | 2022 | Details |
| A50450 | 35386040 | Obes Surg | Bariatric Surgery Improves Nonalcoholic Fatty Liver Disease: Systematic Review and Meta-Analysis. | 2022 | Details |
| A50455 | 35384259 | Liver Int | An MMP-degraded and cross-linked fragment of type III collagen as a non-invasive biomarker of hepatic fibrosis resolution. | 2022 | Details |
| A50519 | 35354928 | Pediatr Res | LncOb rs10487505 variant is associated with leptin levels in pediatric non-alcoholic fatty liver disease. | 2022 | Details |
| A50562 | 35339664 | Diabetes Metab | The triglycerides and glucose (TyG) index: A new marker associated with nonalcoholic steatohepatitis (NASH) in obese patients. | 2022 | Details |
| A50632 | 35320000 | Sci Transl Med | Hepatic IRF3 fuels dysglycemia in obesity through direct regulation of Ppp2r1b. | 2022 | Details |
| A50721 | 35287643 | BMC Endocr Disord | Non-alcoholic fatty liver disease (NAFLD): a review of pathophysiology, clinical management and effects of weight loss. | 2022 | Details |
| A50765 | 35275232 | World J Surg | Bariatric Surgery is Effective and Safe for Obese Patients with Compensated Cirrhosis: A Systematic Review and Meta-Analysis. | 2022 | Details |
| A50780 | 35269515 | Cells | Transcriptomics Reveals Discordant Lipid Metabolism Effects between In Vitro Models Exposed to Elafibranor and Liver Samples of NAFLD Patients after Bariatric Surgery. | 2022 | Details |
| A50784 | 35268293 | J Clin Med | The Utility and Diagnostic Accuracy of Transient Elastography in Adults with Morbid Obesity: A Prospective Study. | 2022 | Details |
| A50790 | 35265372 | J Nutr Metab | The Predictive Role of Parathyroid Hormone for Nonalcoholic Fatty Liver Disease following Bariatric Surgery. | 2022 | Details |
| A51031 | 23376892 | J Hepatol | Regular coffee: a magic bullet or a naked gun? Regular coffee but not espresso drinking is protective against fibrosis in NAFLD. | 2013 | Details |
| A51032 | 23376891 | J Hepatol | Reply to: "regular coffee: a magic bullet or a naked gun? Regular coffee but not espresso drinking is protective against fibrosis in NAFLD". | 2013 | Details |
| A51052 | 20051969 | Nat Rev Gastroenterol Hepatol | Liver: Does bariatric surgery reduce the severity of NAFLD? | 2010 | Details |
| A51069 | 16697746 | Gastroenterology | NAFLD, obesity, and bariatric surgery. | 2006 | Details |
| A51113 | 35688181 | Gastroenterology | Further Insights Into the Impact of Bariatric Surgery on the Progression of Nonalcoholic Fatty Liver Disease. | 2022 | Details |
| A51127 | 35611123 | Case Rep Gastroenterol | Acute Liver Injury and Acute Liver Failure following Bariatric Surgery. | 2022 | Details |
| A51155 | 35447624 | Nephron | Anything New in the Treatment of Obesity in Obese Patients with CKD? | 2022 | Details |
| A51320 | 35629961 | Metabolites | Metabolomics in Bariatric and Metabolic Surgery Research and the Potential of Deep Learning in Bridging the Gap. | 2022 | Details |
| A51530 | 35532410 | J Clin Endocrinol Metab | Serum Thrombospondin-2 Levels Are Closely Associated With the Severity of Metabolic Syndrome and Metabolic Associated Fatty Liver Disease. | 2022 | Details |
| A51662 | 35138516 | Obes Surg | Liver Decompensation after Bariatric Surgery in the Absence of Cirrhosis. | 2022 | Details |
| A51674 | 35040267 | Physiol Rep | Macrophage activation marker sCD163 is associated with liver injury and hepatic insulin resistance in obese patients before and after Roux-en-Y gastric bypass. | 2022 | Details |
| A51690 | 34904501 | Expert Rev Endocrinol Metab | Understanding the pathophysiologic pathways that underlie obesity and options for treatment. | 2021 | Details |
| A51814 | 33946738 | Cells | Hepatic Wnt1 Inducible Signaling Pathway Protein 1 (WISP-1/CCN4) Associates with Markers of Liver Fibrosis in Severe Obesity. | 2021 | Details |
| A51839 | 33803285 | J Clin Med | Sleeve Gastrectomy Is Associated with a Greater Reduction in Plasma Liver Enzymes Than Bypass Surgeries-A Registry-Based Two-Year Follow-Up Analysis. | 2021 | Details |
| A51872 | 33538983 | Obes Surg | Decrease of dipeptidyl peptidase 4 activity is associated with weight loss after bariatric surgery. | 2021 | Details |
| A51904 | 33323476 | Diabetes Care | Presence of Liver Steatosis Is Associated With Greater Diabetes Remission After Gastric Bypass Surgery. | 2020 | Details |
| A52324 | 28614198 | Am J Surg Pathol | The Almost-Normal Liver Biopsy: Presentation, Clinical Associations, and Outcome. | 2017 | Details |
| A52498 | 26337697 | Obes Surg | Changes in Bile Acid Profile After Laparoscopic Sleeve Gastrectomy are Associated with Improvements in Metabolic Profile and Fatty Liver Disease. | 2016 | Details |
| A52512 | 26197299 | Nat Commun | Bile diversion to the distal small intestine has comparable metabolic benefits to bariatric surgery. | 2015 | Details |
| A52546 | 25736229 | Obes Surg | Sleeve Gastrectomy Reduces Hepatic Steatosis by Improving the Coordinated Regulation of Aquaglyceroporins in Adipose Tissue and Liver in Obese Rats. | 2015 | Details |
| A52561 | 25599918 | Int J Surg | Beyond central adiposity: liver fat and visceral fat area are associated with metabolic syndrome in morbidly obese patients. | 2015 | Details |
| A52642 | 24281976 | Curr Cardiol Rep | Impact of obesity and bariatric surgery on metabolism and coronary circulatory function. | 2014 | Details |
| A52718 | 22895358 | Curr Opin Endocrinol Diabetes Obes | Are there still healthy obese patients? | 2012 | Details |
| A52825 | 21252254 | J Clin Endocrinol Metab | Preadipocyte factor-1 is associated with metabolic profile in severe obesity. | 2011 | Details |
| A52873 | 20376319 | PLoS One | The relationship of omental and subcutaneous adipocyte size to metabolic disease in severe obesity. | 2010 | Details |
| A52985 | 18312420 | Eur J Clin Invest | Effect of pronounced weight loss on visceral fat, liver steatosis and adiponectin isoforms. | 2008 | Details |